Prince Akwasi Mensah

Array ( [id] => 1360547 [patent_doc_number] => 06573282 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Peripherally active anti-hyperalgesic opiates' [patent_app_type] => B1 [patent_app_number] => 09/374634 [patent_app_country] => US [patent_app_date] => 1999-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 45118 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573282.pdf [firstpage_image] =>[orig_patent_app_number] => 09374634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384043 [patent_doc_number] => 06277890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Treatment of pulmonary disorders with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli)' [patent_app_type] => 1 [patent_app_number] => 9/363108 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2596 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277890.pdf [firstpage_image] =>[orig_patent_app_number] => 363108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238396 [patent_doc_number] => 06166061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Methods and formulations for modulating the human sexual response' [patent_app_type] => 1 [patent_app_number] => 9/362518 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8934 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166061.pdf [firstpage_image] =>[orig_patent_app_number] => 362518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4104246 [patent_doc_number] => 06051594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Methods and formulations for modulating the human sexual response' [patent_app_type] => 1 [patent_app_number] => 9/362825 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8925 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051594.pdf [firstpage_image] =>[orig_patent_app_number] => 362825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154609 [patent_doc_number] => 06124337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Methods and formulations for modulating the human sexual response' [patent_app_type] => 1 [patent_app_number] => 9/362486 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7732 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124337.pdf [firstpage_image] =>[orig_patent_app_number] => 362486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239427 [patent_doc_number] => 06090819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Use of NK-1 receptor antagonists for treating mania' [patent_app_type] => 1 [patent_app_number] => 9/362277 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24697 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090819.pdf [firstpage_image] =>[orig_patent_app_number] => 362277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296404 [patent_doc_number] => 06197821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Endothelin antagonist' [patent_app_type] => 1 [patent_app_number] => 9/355270 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6535 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197821.pdf [firstpage_image] =>[orig_patent_app_number] => 355270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4206668 [patent_doc_number] => 06077868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Selective inhibition of cyclooxygenase-2' [patent_app_type] => 1 [patent_app_number] => 9/357268 [patent_app_country] => US [patent_app_date] => 1999-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2755 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077868.pdf [firstpage_image] =>[orig_patent_app_number] => 357268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248883 [patent_doc_number] => 06136855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Water-Miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection' [patent_app_type] => 1 [patent_app_number] => 9/356769 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7954 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136855.pdf [firstpage_image] =>[orig_patent_app_number] => 356769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347901 [patent_doc_number] => 06583151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Remedies for drug addiction' [patent_app_type] => B2 [patent_app_number] => 09/297364 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9754 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 757 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583151.pdf [firstpage_image] =>[orig_patent_app_number] => 09297364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314323 [patent_doc_number] => 06242435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Compositions and methods of treating abnormal cell proliferation' [patent_app_type] => 1 [patent_app_number] => 9/351020 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6745 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 440 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242435.pdf [firstpage_image] =>[orig_patent_app_number] => 351020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876826 [patent_doc_number] => 20010006979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'METHOD FOR TREATMENT OF FIBROSIS RELATED DISEASES BY THE ADMINISTRATION OF PROSTACYCLIN DERIVATIVES' [patent_app_type] => new-utility [patent_app_number] => 09/349516 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5812 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006979.pdf [firstpage_image] =>[orig_patent_app_number] => 09349516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099832 [patent_doc_number] => 06048901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Method of reducing intestinal gas, cramping and anorectal irritation' [patent_app_type] => 1 [patent_app_number] => 9/348376 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1280 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048901.pdf [firstpage_image] =>[orig_patent_app_number] => 348376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356073 [patent_doc_number] => 06200958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Agent for treating high-risk impaired glucose tolerance' [patent_app_type] => 1 [patent_app_number] => 9/347028 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5436 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200958.pdf [firstpage_image] =>[orig_patent_app_number] => 347028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260931 [patent_doc_number] => 06204291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Process for promoting weight loss in overweight dogs' [patent_app_type] => 1 [patent_app_number] => 9/337938 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3773 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204291.pdf [firstpage_image] =>[orig_patent_app_number] => 337938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418951 [patent_doc_number] => 06194436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'NK-1 receptor antagonists for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 9/334369 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18239 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194436.pdf [firstpage_image] =>[orig_patent_app_number] => 334369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356184 [patent_doc_number] => 06200966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Compositions for inhibiting airway wall inflammation' [patent_app_type] => 1 [patent_app_number] => 9/330918 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9525 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200966.pdf [firstpage_image] =>[orig_patent_app_number] => 330918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277520 [patent_doc_number] => 06281225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Inhibiting proliferation of arterial smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 9/330314 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9436 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281225.pdf [firstpage_image] =>[orig_patent_app_number] => 330314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156991 [patent_doc_number] => 06103760 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Aminotetralin derivative for the therapy of cardiovascular diseases' [patent_app_type] => 1 [patent_app_number] => 9/328434 [patent_app_country] => US [patent_app_date] => 1999-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3934 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103760.pdf [firstpage_image] =>[orig_patent_app_number] => 328434 [rel_patent_id] =>[rel_patent_doc_number] =>)